A 63-year-old woman with progressive cognitive decline, pyramidal signs, and bilateral cataract was treated by chenodeoxycholic acid following the diagnosis of cerebrotendinous xanthomatosis due to a homozygous variant in <i>CYP27A1</i>. Here, CYP27A1 is linked to cerebrotendinous xanthomatosis.